期刊文献+

原料药生产工艺工业化考虑

Consideration on Industrialization of API Manufacturing Process
下载PDF
导出
摘要 本文论述了原料药生产工艺工业化应考虑的六个方面,有效引导药物研发工作者在工艺开发前期应关注因素,预测和判断放大生产前存在技术、安全、操作等风险,从而针对性的开展生产放大可行性研究,有效规避生产偏差发生,最大限度降低财产损失,保障我国原料药生产规模化运营。 This paper discusses six aspects that should be considered in the industrialization of API manufacturing process.It effectively guides the drug R&D workers to pay attention to the factors in the early stage of process development,and predict and judge technology,safety,operational and other risks before scaling up the manufacturing,so as to conduct scale-up feasibility studies,prevent deviations and minimize property losses to ensure the large-scale API manufacturing in China.
作者 戚郜飞 徐士伟 金爱民 张春红 Qi Gaofei;Xu Shiwei;Jin Aimin;Zhang Chunhong(Hansoh Pharmaceutical Co.,Ltd.,Lianyungang222000,China)
出处 《山东化工》 CAS 2020年第17期132-133,共2页 Shandong Chemical Industry
关键词 生产工艺 工业化 放大可行性研究 manufacturing process industrialization feasibility studies
  • 相关文献

参考文献10

二级参考文献40

  • 1ICH. ICH harmonized tripartite guideline,pharmaceutical develop- ment QS[S/OL]. (2009) [2014-03 - 15]. hnp://www, ich. org/products/guidelines, html.
  • 2ICH. ICH harmonized tripartite guideline,quality risk management Q9[S/OL]. (2008) [2014 -03 - 151. http://www, ich. org/ products/guidelines, html.
  • 3ICH. ICH harmonized tripartite guideline, pharmaceutical quality system Q10[S/OL]. (2008) [2014 -03 - 15]. http://www. ich. org/products/guidelines, html.
  • 4PAUL AD, WANG WL, PAUL WS, et al. Clinical relevance of dissolution testing in quality by design [ J 1. AAPS J, 2008, 10 (2) : 380 - 390.
  • 5SIEGFRIED A, DANIELE S, CHARLES R, et al. An integrated Quality by Design (QbD) approach towards design space definition of a blending unit operation by Discrete Element Method (DEM) simulation [ J ]. Eur J Pharm Sci, 2011, 42 : 106 - 115.
  • 6ANNA G, ANTONELLO AB, DAVIDE F. On the use of mathe- matical models to build the design space for the primary drying phase of a pharmaceutical lyophilization process [ J ]. J Pharm Sci, 2011, 100(1) :311 -324.
  • 7HUIQUAN W, MAURY W, MANSOOR AK. Quality-by-sesign (QbD) : An integrated process analytical technology (PAT) ap- proach for a dynamic pharmaceutical co-precipitation process char- acterization and process design space development [ J ]. lnt J Pharm,2011, 405(1 -2) :63 -78.
  • 8VERA L, DIRK L, GABRIELE R, etal. A quality by design study applied to an industrial pharmaceutical fluid bed granulation [J]. Eur JPharm Biopharm,2012, 81(2): 438 -447.
  • 9ANASTASIA GL,JOHN WM. Evaluation of the microbial growth potential of pharmaceutical drug products and quality by design [J]. PDA J Pharm Sci Tech,2011, 65(1):63-70.
  • 10LAWRENCE XY. Pharmaceutical quality by design: product and process development, understanding and control[ J ]. Pharm Res, 2008, 25(4) :781 -791.

共引文献112

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部